当前位置:首页 - 行情中心 - 亚太药业(002370) - 财务分析 - 现金流量表

亚太药业

(002370)

  

流通市值:38.18亿  总市值:38.18亿
流通股本:7.46亿   总股本:7.46亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金97,607,910.7845,882,217.33225,955,460.31146,928,758.56
  收到其他与经营活动有关的现金9,284,373.63,913,663.1449,779,354.4236,121,132.68
  经营活动现金流入小计106,892,284.3849,795,880.47275,734,814.73183,049,891.24
  购买商品、接受劳务支付的现金72,350,835.338,544,107.92104,480,130.7153,945,864.39
  支付给职工以及为职工支付的现金37,820,669.0522,530,444.8167,346,780.751,439,097.1
  支付的各项税费8,790,452.36,190,404.4617,206,501.9614,931,678.16
  支付其他与经营活动有关的现金56,143,256.9714,729,815.0957,805,039.2539,184,293.41
  经营活动现金流出小计175,105,213.6551,994,772.28246,838,452.62159,500,933.06
  经营活动产生的现金流量净额-68,212,929.27-2,198,891.8128,896,362.1123,548,958.18
二、投资活动产生的现金流量:
  收回投资收到的现金104,926,00920,000,00061,175,934.5531,175,934.55
  取得投资收益收到的现金1,117,858.9545,718.391,111,988.31912,448.6
  处置固定资产、无形资产和其他长期资产收回的现金净额--9,199.617,900
  处置子公司及其他营业单位收到的现金净额--174,780,657.82126,268,279.93
  收到的其他与投资活动有关的现金6,917,839.5564,450.672,119,972.0450,767,599.96
  投资活动现金流入小计112,961,707.520,110,169.06239,197,752.33209,132,163.04
  购建固定资产、无形资产和其他长期资产支付的现金7,143,426.551,983,027.335,052,612.634,351,564.63
  投资支付的现金134,935,24850,000,00060,000,00060,000,000
  支付其他与投资活动有关的现金10,000,000---
  投资活动现金流出小计152,078,674.5551,983,027.3365,052,612.6364,351,564.63
  投资活动产生的现金流量净额-39,116,967.05-31,872,858.27174,145,139.7144,780,598.41
三、筹资活动产生的现金流量:
  吸收投资收到的现金4,000,000---
  其中:子公司吸收少数股东投资收到的现金4,000,000---
  筹资活动现金流入平衡项目0---
  筹资活动现金流入小计4,000,000---
  偿还债务支付的现金--277,225,300277,225,300
  分配股利、利润或偿付利息支付的现金--37,371,378.3437,371,378.34
  筹资活动现金流出平衡项目--00
  筹资活动现金流出小计--314,596,678.34314,596,678.34
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额4,000,000--314,596,678.34-314,596,678.34
五、现金及现金等价物净增加额-103,329,896.32-34,071,750.08-111,555,176.53-146,267,121.75
  加:期初现金及现金等价物余额608,143,546.73608,143,546.73719,698,723.26719,698,723.26
  期末现金及现金等价物余额504,813,650.41574,071,796.65608,143,546.73573,431,601.51
补充资料:
  净利润-516,346.76-96,307,827.65-
  资产减值准备3,040,255-23,103,284.03-
  固定资产和投资性房地产折旧11,845,936.34-25,984,748.44-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧11,845,936.34-25,984,748.44-
  无形资产摊销2,564,734.11-5,619,912.2-
  长期待摊费用摊销--156,600-
  处置固定资产、无形资产和其他长期资产的损失--57,942.49-
  固定资产报废损失--73,387.54-
  公允价值变动损失7,119,515.01--830,085.38-
  财务费用--32,584,779.17-
  投资损失-1,117,584.39--150,238,962.52-
  递延所得税-1,067,927.26-124,512.81-
    递延所得税负债增加-1,067,927.26-124,512.81-
  存货的减少14,931,058.25--49,442,609.96-
  经营性应收项目的减少-16,253,899.09-59,313,266.19-
  经营性应付项目的增加-91,812,379.5--13,059,258.42-
  债务转为资本--17,081,344-
  现金的期末余额504,813,650.41-608,143,546.73-
  减:现金的期初余额608,143,546.73-719,698,723.26-
  现金及现金等价物的净增加额-103,329,896.32--111,555,176.53-
公告日期2026-08-262026-04-252026-04-252025-10-29
审计意见(境内)标准无保留意见
TOP↑